Floatz logo

Tiagabine

Mental Retardation

Oslo University HospitalSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Mental Retardation cohort.

Asset / SponsorPhaseRating
LAMOTRIGINE
Oslo University Hospital
Phase 4BB
Topamax
Oslo University Hospital
Phase 4BB
Felbamate
Oslo University Hospital
Phase 4BB
Carbamazepine
Oslo University Hospital
Phase 4BB
Keppra
Oslo University Hospital
Phase 4BB

View all 16 →

Same molecule, other indications

Tiagabine is also rated in:

focal epilepsyDormant
BB
Indicative ·
68 / 100
View asset →
epilepsyDormant
B
Indicative ·
59 / 100
View asset →
schizophreniaDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →